InvestorsHub Logo
Followers 77
Posts 11422
Boards Moderated 0
Alias Born 04/03/2014

Re: midastouch017 post# 3057

Thursday, 08/26/2021 7:22:45 AM

Thursday, August 26, 2021 7:22:45 AM

Post# of 3965
From the PR

Good part “Nearing the end of extensive review, Quantum Leap Healthcare Collaborative and the U.S. government's Biomedical Advanced Research and Development Authority (BARDA) are close to selection of opaganib for inclusion in the I-SPY COVID-19 Trial, with funding for opaganib provided by BARDA.
The I-SPY platform is intended for rapidly testing promising therapeutic candidates for severely ill COVID-19 patients.”

Not so good - FDA has indicated that additional trials will be needed for full approval.

They have $78 million in cash - not sufficient for 2 new products.
So hope they will wait for the topline results - if the results are good to great - the SP will spike and they can raise more money at higher price and low dilution

Fingers crossed - it is like we have written exam paper and nothing in our hand and waiting for results
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RDHL News